Evolutionary Approaches to the Patient with Pulmonary Arterial Hypertension

Jointly Provided by the University of Cincinnati and PlatformQ Health, Inc.

ACKNOWLEDGEMENT
This activity is supported by educational grants provided by Actelion Pharmaceuticals US, Inc. and Bayer HealthCare Pharmaceuticals, Inc.

TUITION
Complimentary

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and PlatformQ Health Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Live Internet Activity
The University of Cincinnati designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The University of Cincinnati designates this Enduring Material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION
Live Activity
Tuesday, June 28, 2016, 10:00 AM - 11:00 AM EST

Enduring Material

The enduring material will be available from June 28, 2016 - December 28, 2016.

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Identify patient factors that would lead to a high index of suspicion for PAH as the cause of non-specific dyspneic symptoms
Describe recommended testing procedures to establish a PAH diagnosis
Assess the evidence for newer PAH drug treatment regimens with respect to impact on morbidity and mortality
Discuss emerging treatments for PAH and their potential place in therapy


TARGET AUDIENCE

The activity is intended for cardiologists, pulmonologists, radiologists, hospitalists, intensive care specialists, internists, primary care clinicians, and other health care professionals caring for patients with PAH.

ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to http://www.CardioCareLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.


HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FINANCIAL DISCLOSURES

Presenters Disclosures:
Harrison W. Farber, MD, FAHA, FCCP

TBD

   
Moderator TBD
   

University of Cincinnati  
Susan P. Tyler, MEd, CMP, CHCP, Director

Has nothing to disclose

Rick Ricer, MD, CME Physician Reviewer

Has nothing to disclose


PlatformQ Health, Inc.  
Carolyn Skowronski, PharmD, Medical Director

Shareholder: Merck

Karen Greb-Murphy, Program Manager

Has nothing to disclose


DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
The University of Cincinnati requires the presenter(s) to inform the audience when off-label or unapproved uses of drugs or devices are being discussed. Devices or drugs that are still undergoing clinical trials will be identified as such and will not be portrayed as standard, accepted therapy.

DISCLAIMER:
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the University of Cincinnati, CardioCareLive, PlatformQ Health or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

CONTACT INFORMATION

Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

Technical Support:
For any technical issues or issues with your CME Certificate, contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com


Advances in Heart Failure Management: Improving Outcomes with Innovation

Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC


ACKNOWLEDGEMENT

This activity is supported by an independent educational grant from Novartis Pharmaceutical Corporation.

TUITION
Complimentary

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION
Live Internet Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION
Live Activity
Tuesday, September 27, 2016, from 1:00 PM – 3:00 PM EST
Tuesday, November 1, 2016, from 2:00 PM – 3:00 PM EST.

Enduring Material
The enduring material will be available from September 27, 2016 – May 1, 2017.

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Implement heart failure classification systems, such as the ACC/AHA stages or NYHA functional classification, in order to effectively stage patients and direct treatment goals
Evaluate the role of biomarkers as prognostic indicators, and to monitor therapy for patients with reduced or preserved ejection fraction heart failure
Implement pivotal study data for recently approved therapies for patients with heart failure
Evaluate pivotal study data for recently approved therapies for patients with heart failure
Implement electricity and catheter-based therapies for heart failure patients who are appropriate candidates
Appraise clinical trial data for emerging interventions for patients with advanced heart failure
Compare and contrast clinical trial data for emerging therapies and interventions
Prescribe evidence-based approaches to real heart failure cases


TARGET AUDIENCE

This activity is intended for cardiologists, interventional cardiologists, internal medicine and primary care physicians, and other health care professionals who treat patients with heart failure.

ESTIMATED TIME TO COMPLETE
This activity consists of four sessions, which should take approximately 3 hours to complete.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to http://www.IDCareLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Media-Internet

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Akshay Suvas Desai, MD, MPH

Consulting Fees: Novartis; Merck; Relypsa Inc.; St. Jude Medical; Sanofi
Contracted Research: Novartis

James L. Januzzi, Jr., MD, FACC, FESC

Consulting Fees: Roche Diagnostics; Critical Diagnostics; Philips; Novartis; Metanomics; Janacare
Contracted Research: Siemens; Prevencio; Singulex
Other Endpoint Committees: Boehringer-Ingelheim; Janssen; AbbVie; Pfizer; Merck

Jagmeet P. Singh, MD, PhD

Consulting Fees: Biotronik; Boston Scientific; St. Jude Medical; Medtronic; Impulse Dynamics; Respicardia, Inc.
Contracted Research: St. Jude Medical; Boston Scientific


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


Name of planner Reported Financial Relationship
Agnes Lee, MD
Medical Director
PlatformQ Health Education, LLC

None


The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following PlatformQ Health Education, LLC planner, Karen Greb-Murphy, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
Please contact the Postgraduate Institute of Medicine at www.pimed.com.

Technical Support:
For any technical issues or issues with your CME Certificate, contact IDCareLive at 877-394-1306 or at Support@IDCareLive.com

Anticoagulation in the Era of Newer Target-Specific Oral Agents

Presented by the Albert Einstein College of Medicine and Montefiore Medical Center in Joint Providership with PlatformQ Health, LLC.

ACKNOWLEDGEMENT
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi-Sankyo, Inc.

TUITION
Complimentary

ACCREDITATION STATEMENT
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Live Internet Activity
Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hour of Category 1 credit for completing this program.

DATE OF RELEASE/EXPIRATION
Live Activity
Friday, October 7, 2016 1:00PM EST - 2:00PM EST

Enduring Material

The enduring material will be available from June 28, 2016 - December 28, 2016.

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Identify barriers to acheiving guidline-recommended anticoagulation
Assess the safety profiles of NOACs compared with warfarin in multiple disease settings, including atrial fibrillation, venous thromboembolism, and pulmonary embolism
Compare and contrast the administration, clinical efficacy, and safety of antidotes for the reversal of anticoagulant effects of warfarin and NOACs in patients who require emergency anticoagulation reversal


INTENDED AUDIENCE

Cardiologists, emergency department specialists, intensive care specialists, surgeons, hospitalists, internists, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other health care professionals caring for patients requiring antithrombotic therapy.

ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.


HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURES
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

Presenters Disclosures
Elaine Hylek, MD, MPH

TBD

Christian T. Ruff, MD, MPH Consulting Fee: Daiichi-Sankyo, Boehringer Ingelheim, Bayer
   
Peer Reviewer Disclosures
Henry Billett, MD, MSc

TBD


Providers Disclosures
Einstein-Montefiore Center for Continuing Medical Education

The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.


PlatformQ Health, LLC. Disclosures
Agnes Lee, Medical Director

Has nothing to disclose relevant to this activity.

Randi O'Hara, Senior Program Manager

Has nothing to disclose relevant to this activity


DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

DISCLAIMER:
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, CardioCareLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

CONTACT INFORMATION

Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org

Technical Support:
For any technical issues or issues with your CME Certificate, contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com

 
CardioCareLive
Watch Connect online with thousands of your peers.
Connect Engage in real-time Q&A with top factuly.
Choose Learn about the latest treatment options.
Connect Earn AMA PRA
Category 1 Credits
™.